1. A Retrospective Comparative Outcomes and Cost Analysis of Office Based, Ultrasound Guided Renal Mass Biopsy Performed by Urologists and Standard Hospital Biopsies for Small Renal Masses. Issue 4 (July 2018) Authors: Faraj, Kassem; Dave, Chirag N.; Patel, Kunal; Seifman, Brian; Vartanian, Stephen; Frontera, Rene; Nelson, Ryan; Hafron, Jason; Schervish, Edward W. Journal: Urology practice Issue: Volume 5:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adherence With Oral Anticancer Therapies: Clinical Trial vs Real-world Experiences With a Focus on Prostate Cancer. Issue 3 (6th March 2023) Authors: Higano, Celestia S.; Hafron, Jason Journal: Journal of urology Issue: Volume 209:Issue 3(2023) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Benign prostate hyperplasia as a potential protective factor against prostate cancer: Insights from a magnetic resonance imaging study of compositional characteristics. Issue 14 (10th August 2021) Authors: Nandalur, Kiran R.; Colvin, Robert; Walker, David; Nandalur, Sirisha R.; Seifman, Brian; Gangwish, David; Hafron, Jason Journal: Prostate Issue: Volume 81:Issue 14(2021) Page Start: 1097 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chromogranin a staining as a prognostic variable in newly diagnosed Gleason score 7–10 prostate cancer treated with definitive radiotherapy. Issue 5 (30th December 2013) Authors: Krauss, Daniel J.; Amin, Mitual; Stone, Brandon; Ye, Hong; Hayek, Sylvia; Cotant, Matthew; Hafron, Jason; Brabbins, Donald S. Journal: Prostate Issue: Volume 74:Issue 5(2014) Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of the bladder detrusor muscular ring on lower urinary tract symptoms due to benign prostatic hyperplasia: A quantitative MRI analysis. Issue 3 (7th November 2022) Authors: Nandalur, Kiran R.; Walker, David; Ye, Hong; Al‐Katib, Sayf; Seifman, Brian; Gangwish, David; Dhaliwal, Abhay; Connor, Ervin; Dobies, Kayla; Sesoko, Channing; Dejoie, Wesley; Zwaans, Bernadette; Nandalur, Sirisha; Nguyen, Jennifer; Hafron, Jason Journal: Prostate Issue: Volume 83:Issue 3(2023) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Magnetic resonance imaging‐guided transurethral ultrasound ablation in patients with localised prostate cancer: 3‐year outcomes of a prospective Phase I study. (1st November 2020) Authors: Nair, Shiva M.; Hatiboglu, Gencay; Relle, James; Hetou, Khalil; Hafron, Jason; Harle, Christopher; Kassam, Zahra; Staruch, Robert; Burtnyk, Mathieu; Bonekamp, David; Schlemmer, Heinz‐Peter; Roethke, Matthias C.; Mueller‐Wolf, Maya; Pahernik, Sascha; Chin, Joseph L. Journal: BJU international Issue: Volume 127:Number 5(2021) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MP27-17 NIRAPARIB WITH ABIRATERONE ACETATE AND PREDNISONE FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE PHASE 2 QUEST STUDY. (May 2022) Authors: Chi, Kim; Fleshner, Neil; Chiuri, Scaranos, Vincenzo Emanuele; Van Bruwaene, Siska; Hafron, Jason; McNeel, Douglas G.; De Porre, Peter; Maul, R. Scott; Daksh, Mahesh; Zhong, Xiaogang; Mason, Gary E.; Tutrone, Ronald Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MRI-guided transurethral ultrasound prostate ablation: midterm outcomes of a phase I clinical trial. Issue 1 (December 2015) Authors: Burtnyk, Mathieu; Billia, Michele; Popeneciu, Ionel; Hafron, Jason; Roethke, Matthias; Schlemmer, Heinz-Peter; Relle, James; Pahernik, Sascha; Chin, Joseph Journal: Journal of therapeutic ultrasound Issue: Volume 3:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines. Issue 6 (4th March 2020) Authors: Shore, Neal D.; Antonarakis, Emmanuel S.; Cookson, Michael S.; Crawford, E. David; Morgans, Alicia K.; Albala, David M.; Hafron, Jason; Harris, Richard G.; Saltzstein, Daniel; Brown, Gordon A.; Henderson, Jonathan; Lowentritt, Benjamin; Spier, Jeffrey M.; Concepcion, Raoul Journal: Prostate Issue: Volume 80:Issue 6(2020) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PD35-07 ANALYSIS OF DISCONTINUATION RATES AND CAUSES OF EARLY DISCONTINUATION OF NOVEL ORAL HORMONE THERAPY IN MEN WITH ADVANCED PROSTATE CANCER. (1st May 2022) Authors: Gangwish, David; Zwaans, Bernadette; Miriani, Paul; Dejoie, Wesley; Ajo, Andrina; Ervin, Connor; Sarazin, Jeff; Hafron, Jason Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗